Gliosarcoma with Systemic Metastasis Showing Favorable Response to Ifosfamide, Carboplatin, and Etoposide Chemotherapy: An Autopsy Case Report

Gliosarcoma is a rare malignant neoplasm. It accounts for approximately 2% of all glioblastomas. To date, there is no established treatment method for gliosarcoma, and a variety of therapies, such as surgical resection, radiotherapy, and chemotherapy, are typically employed. Here, we describe a pati...

Descripción completa

Detalles Bibliográficos
Autores principales: NAKAGAKI, Yuki, KAI, Keitaro, KOMOHARA, Yoshihiro, TAKEZAKI, Tatsuya, KURODA, Junichiro, SHINOJIMA, Naoki, SHIMOMURA, Mari, KAWAKAMI, Fumi, MIKAMI, Yoshiki, MUKASA, Akitake
Formato: Online Artículo Texto
Lenguaje:English
Publicado: The Japan Neurosurgical Society 2022
Materias:
Case Report
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9484818/
https://www.ncbi.nlm.nih.gov/pubmed/36186622
http://dx.doi.org/10.2176/jns-nmc.2022-0075

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9484818/
https://www.ncbi.nlm.nih.gov/pubmed/36186622
http://dx.doi.org/10.2176/jns-nmc.2022-0075

Ejemplares similares